
News|Articles|July 30, 2025
Could targeting retinal non-perfusion be the key to achieving true disease modification in diabetic retinopathy?
Advertisement
Sponsored Supplement:
The triad of inflammation, neuropathy, and vasculopathy plays a key role in the development and progression of diabetic retinopathy (DR).1 Dr. Varun Chaudhary and Dr. Patrick Bussfeld, discuss how retinal non-perfusion (RNP) specifically drives disease progression and why it should be explored as a treatment target.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
2
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis
3
ARPA-H funds tear-duct biosensor system for dry eye, systemic disease
4
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
5























